Search Results 1101-1110 of 17073 for monoclonal antibody
Participation eligibility · History of severe allergic or anaphylactic reactions to monoclonal antibodies or known hypersensitivity to any component of the ...
Patients who have received any continuous or intermittent small molecule therapeutics (excluding monoclonal antibodies) ≤ 5 effective half-lives prior to ...
The primary objective of this study is to assess the effectiveness of fostamatinib in subjects with warm antibody autoimmune hemolytic anemia (wAIHA). A Study ...
Treatment with any investigational products or with chimeric or fully human monoclonal antibodies within 30 days before randomization, systemic anticancer ...
Currently taking paclitaxel (mitotic inhibitor), natalizumab (anti-integrin monoclonal antibody), or any other anti-integrin treatment. Routine consumption ...
Subject who received any prior monoclonal antibodies against PD-1 or PD-L1 and/or any prior: Arm A only: ImiDs (eg, lenalidomide, thalidomide);; Arm B ...
Participation eligibility · Subjects who are hepatitis B core antibody (anti-HBc) positive and who are surface antigen negative will need to have a negative ...
Monoclonal antibody drugs · Mort Crim and Cancer · Mouth sores caused by cancer treatment: How to cope · Muscle cramp · Muscle strains · Myalgic ...
... monoclonal antibody will be reviewed case-by-case by the sponsor. Participating Mayo Clinic locations. Study statuses change often. Please contact the study ...
Known severe allergic reactions to TCZ or other monoclonal antibodies. Active TB infection. Suspected active bacterial, fungal, viral, or other infection ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.